| 26 | Glucosenz | 2020-006-B |  |
| 27 | Gene Therapy In Hemophilia A | 2020-005-B | |
| 28 | Rapid And Digital Detection Of Inflammatory Biomarkers Enabled By A Novel Portable Nanoplasmic Imager (DENIS) | 2020-004-S | |
| 29 | STUHL | 2020-004-B | |
| 30 | Belantamab Mafodotin For Relapsed/Refractory Multiple Myeloma (RRMM) | 2020-003-S | |
| 31 | Teprotumumab For The Treatment Of Thyroid Eye Disease (TED) | 2020-003-B | |
| 32 | Takeda Dengue Vaccine (TDV/TAK-003) | 2020-002-B | |
| 33 | Reversible Inhibition Of Sperm Under Guidance (RISUG) | 2020-001-S | |
| 34 | Polypill For Cardiovascular Disease Prevention | 2020-001-B | |
| 35 | ITCA 650 | 2019-018-S | |
| 36 | EpicHeart For Advanced Heart Failure | 2019-017-S | |
| 37 | Brolucizumab (RTH258) For Neovascular Age-Related Macular Degeneration (NAMD) | 2019-016-S | |
| 38 | Unpowered Ankle Exoskeleton | 2019-015-S | |
| 39 | ENTRECTINIB for Neurotrophic Tropomyosin Receptor Kinase (NTRK) Fusion-Positive, Locally Advanced Or Metastatic Solid Tumours_ And Metastatic, ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) | 2019-014-S | |
| 40 | Bempedoic Acid (ETC-1002) For Patients With Atherosclerotic CVD On Maximally-Tolerated Statins Or Statin Intolerance | 2019-013-S | |
| 41 | S5 DNA Methylation Classifier (Epigenetic-Based Test) For Cervical Cancer Screening | 2019-011-S | |
| 42 | Percepta Bronchial Genomic Sequencing Classifier For Lung Cancer Screening | 2019-010-S | |
| 43 | Iclaprim for Acute Bacterial Skin and Skin Structure Infections | 2019-007-S | |
| 44 | Diroximel Fumarate (ALKS 8700 BIIB0998) For Relapsing-Remitting Multiple Sclerosis | 2019-006-S | |
| 45 | NEUVAX™ (Nelipepimut-S, NP-S) For Recurrence Breast Cancer | 2019-006-B | |
| 46 | BILISPEC | 2019-005-S | |
| 47 | Targeted Low Dose Radiotherapy For Early Breast Carcinoma Post Breast-Conserving Surgery | 2019-004-B | |
| 48 | Quizartinib For Treatment Of Patients With Relapsed/Refractory Fms-Like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) Acute Myeloid Leukaemia (AML) | 2019-003-S | |
| 49 | EZ Weigh | 2019-003-B | |
| 50 | Adjunctive Tecentriq In PD-L1-Positive Unresectable Locally Advanced Or Metastatic Triple-Negative Breast Cancer | 2019-002-S | |
.png)
